Why the study?
Bovine rotavirus A causes severe economic losses from calf diarrhea, and understanding the occurrence frequency of G and P genotypes was needed to establish protective strategies using immunoglobulin yolks.
Does anti-bovine RVA immunoglobulin yolk show cross-reactivity against bovine RVAs with different genotypes?
Does anti-bovine RVA immunoglobulin yolk show cross-reactivity against bovine RVAs with different genotypes?
Anti-bovine RVA IgYs show strong cross-reactivity against bovine RVAs with the same G and/or P genotypes, suggesting potential for passive immunization in calves.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for IgY passive immunization against homologous bovine RVA; leaves open heterologous genotype efficacy.
Bovine rotavirus A (RVA), a major causative pathogen of diarrhea in dairy and Japanese beef calves, has led to severe economic losses in numerous countries. A dual genotyping system based on genomic segments encoding VP7 (G genotype) and VP4 (P genotype), comprising the outer layer of the virion, has been used to understand the epidemiological dynamics of RVAs at the national and global levels. This study aimed to investigate occurrence frequency of G and P genotypes for multiple bovine RVAs from calf diarrheic samples collected in Japan from 2017 to 2020. After we produced anti-bovine RVA immunoglobulin yolks (IgYs) from hens immunized with the two RVAs with different genotypes (G6P[5] and G10P[11]) selected on the basis of the current epidemiological survey, we investigated cross-reactivity against bovine RVAs with different G and P combinations owing to establish a useful strategy to protect calves from RVA infections using the two IgYs. Consequently, the two produced anti-bovine IgYs showed strong cross-reactivity against bovine RVAs with the same G and/or P genotypes in neutralization assay, respectively. Therefore, our data suggest the possibility of a passive immunization to protect calves from a bovine RVA infections epidemic in Japan via oral administration of the two IgYs into calves. The findings presented herein will provide important information that IgY is one of the effective tools to prevent infections of various pathogens.
No takes yet. Share an insight, caveat, or question.
Odagiri et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: